Is MDCT an accurate tool to differentiate between benign and malignant etiology in diffuse peritoneal disease?
- 17 August 2022
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (11) , 3921-3929
Abstract
Purpose There is often considerable overlap of imaging findings in benign and malignant peritoneal diseases. We evaluated patients with diffuse peritoneal disease, to assess the diagnostic value of MDCT in predicting benign or malignant etiology in patients with unknown etiology, by analyzing the various patterns of involvement, particularly tuberculosis (TB) vs malignancy. Methods One hundred and thirty-six patients with diffuse peritoneal disease who had abdominal CT and subsequently underwent omental biopsies were included in the study. Peritoneal, mesenteric and omental involvement by disease was evaluated on CT using specific parameters. The presence of lymphadenopathy, ascites, scalloping of organs, involvement of liver and spleen, were also compared between benign and malignant conditions using histopathology as the gold standard. Results In 136 patients, 72 benign and 64 malignant pathologies were classified as per histopathology. Higher age (p < 0.001), increasing omental thickness (mean 25.2 mm, p = 0.004), omental caking (p < 0.001), > 10 mm mesenteric/peritoneal nodules (p < 0.03), visceral scalloping (p = 0.001), free ascites (p = 0.003), serosal involvement (p = 0.004) and bilateral pleural effusion (p = 0.02) were associated with malignant etiology. Mesenteric thickening/stranding (p = 0.02), mesenteric adenopathy (p < 0.001), necrotic nodes (p = 0.02), splenomegaly (p = < 0.001) and higher attenuation (> 20HU) of ascitic fluid (p < 0.001) were associated with benign etiology. The presence of mesenteric thickening or stranding (p = 0.01), splenomegaly (p = 0.02), higher ascitic fluid attenuation > 20HU (p = < 0.01), mesenteric adenopathy (p < 0.01), necrotic nodes (p = 0.03) favored tuberculosis. CT had diagnostic accuracy (79.3, 86.7%), sensitivity (79.2, 74.6%) and specificity (79.4, 97%) for observers 1 and 2, respectively (Kappa 0.713). Conclusion Contrast-enhanced MDCT has good sensitivity, specificity and accuracy in differentiating benign and malignant etiologies of diffuse peritoneal disease. Multiple common parameters can be used to differentiate between tuberculous peritonitis and peritoneal carcinomatosis. Graphical abstractKeywords
Funding Information
- Institutional fluid research grant (IRB Min. No. 11092)
This publication has 19 references indexed in Scilit:
- CT imaging of peritoneal carcinomatosis and its mimicsDiagnostic and Interventional Imaging, 2014
- Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125Revista Española de Medicina Nuclear e Imagen Molecular, 2014
- Peritoneal Carcinomatosis in Patients With Ovarian CancerClinical Nuclear Medicine, 2013
- Peritoneal and Retroperitoneal Anatomy and Its Relevance for Cross-Sectional ImagingRadioGraphics, 2012
- Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancerBritish Journal of Surgery, 2012
- Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006Clinical Infectious Diseases, 2009
- Secondary Tumors and Tumorlike Lesions of the Peritoneal Cavity: Imaging Features with Pathologic CorrelationRadioGraphics, 2009
- Primary Neoplasms of Peritoneal and Sub-peritoneal Origin: CT FindingsRadioGraphics, 2005
- The greater omentum.American Journal of Roentgenology, 1997
- CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis.American Journal of Roentgenology, 1996